Barone Angelica

Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD / C. Rusconi, A. Barone, A. Visentin, B. Bianchi, V.R. Zilioli, A. Bernardelli, S. Iadecola, E. Olivari, F.G. Rossi, M. Gotti, C. Cecchetti, B. Puccini, S. Franceschetti, A. Molteni, S. Steffanoni, F. Marino, A. Vanazzi, A. Guidetti, M. Merli, F. Mazzon, A. Marchetti, A. Cellini, C. Muzi, R. Miceli, C. Visco, A. Re, P. Corradini. - In: LEUKEMIA & LYMPHOMA. - ISSN 1029-2403. - 66:5(2025), pp. 879-887. [10.1080/10428194.2024.2446609]

Prospective Validation of CAR-HEMATOTOX and a simplified version predict Survival in Patients with Large B-Cell Lymphoma treated with anti-CD19 CAR T-cells: data from CART-SIE study / F. Stella, M. Pennisi, A. Chiappella, B. Casadei, S. Bramanti, S. Ljevar, P. Chiusolo, A.D. Rocco, M.C. Tisi, P. Angelillo, I. Cutini, M. Martino, A. Barone, F. Bonifazi, A. Santoro, F. Sorà, M. Novo, A.M. Barbui, D. Russo, M. Musso, G. Grillo, M. Krampera, J. Olivieri, L. Brunello, F. Cavallo, M. Massaia, L. Arcaini, L. Farina, P. Zinzani, R. Miceli, P. Corradini. - In: TRANSPLANTATION AND CELLULAR THERAPY. - ISSN 2666-6367. - 31:4(2025), pp. 1-9. [10.1016/j.jtct.2025.01.888]

Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE study / A. Barone, A. Chiappella, B. Casadei, S. Bramanti, S. Ljevar, P. Chiusolo, A. Di Rocco, M.C. Tisi, A.M. Barbui, M. Farina, L. Brunello, M.C. Di Chio, M. Novo, M. Musso, J. Olivieri, G.E. Trotta, A. Dodero, A. Aiello, P. Corradini. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 1365-2141. - (2024), pp. 1-5. [10.1111/bjh.19590]